After two decades without news, in the last year the US has approved two drugs that manage to slow the progression of this pathology in the initial stages. Together with blood biomarkers, they represent the beginning of a new time to which experts look with optimism.
Alzheimer’s is known for its cruelest symptom: forgetfulness. A lack of memory that ends up making the patient absolutely dependent for everything. Approximately 70% of cases begin with problems remembering.
In Spain, about 800,000 people live with this disease …
Session limit reached
- Access to Premium content is open courtesy of the establishment you are in, but right now there are too many users logged in at once. Please try again after a few minutes.
try again
You have exceeded the session limit
- You can only have three sessions started at a time. We have closed the oldest session so you can continue browsing the rest without limits.
Keep browsing
Article for subscribers only
Report a bug
#era #Alzheimers #biomarkers #drugs #ahead #disease
